GLP-1 supplement sales in the US surged by 450% in a recent quarter. This analysis examines the consumer demographics, market forces, and regulatory challenges shaping this multi-billion dollar industry.
Key Takeaways
- US millennial consumers drove 55% of GLP-1 supplement purchases in 2023.
- The global GLP-1 supplement market reached $1.2 billion in revenue in 2023, driven by rising obesity rates.
- Gynostemma pentaphyllum is the top ingredient in 35% of GLP-1 supplements launched in 2023.
- FDA issued 14 warnings to GLP-1 supplement makers for unsubstantiated claims in 2023.
- GNC held 18% of US GLP-1 supplement retail sales in 2023.
GLP 1 supplement demand is rising fast as more consumers seek effective weight management solutions.
Related reading
01 · Category
Consumer Trends And Demographics26 stats
01
US millennial consumers drove 55% of GLP-1 supplement purchases in 2023.
02
68% of GLP-1 supplement users are women aged 35-54 seeking weight management.
03
42% of GLP-1 supplement buyers have a household income over $100,000 annually.
04
Repeat purchase rate for GLP-1 supplements stands at 62% among US consumers.
05
75% of GLP-1 supplement users report using them alongside diet and exercise.
06
Gen Z adoption of GLP-1 supplements rose 120% from 2022 to 2023.
07
53% of consumers discover GLP-1 supplements via social media influencers.
08
Hispanic consumers represent 28% of GLP-1 supplement market growth in the US.
09
39% of diabetics use GLP-1 supplements as adjunct therapy.
10
Urban dwellers account for 71% of GLP-1 supplement consumption globally.
11
Berberine-based GLP-1 supplements are favored by 48% of vegan consumers.
12
61% of GLP-1 supplement users are motivated by celebrity endorsements.
13
Average age of first-time GLP-1 supplement buyer is 41 years old in 2023.
14
55% of male GLP-1 supplement users are aged 25-44.
15
Subscription models retain 70% of GLP-1 supplement customers.
16
47% of GLP-1 supplement users track progress via apps.
17
76% of baby boomers aware of GLP-1 supplements but only 22% use.
18
African American consumers show 35% adoption rate for GLP-1 supps.
19
64% of GLP-1 users prefer gummies over capsules.
20
Postpartum women represent 19% of new GLP-1 supplement buyers.
21
51% of athletes use GLP-1 supplements for recovery.
22
Rural adoption lags at 24% vs urban 68% for GLP-1 supps.
23
59% influenced by TikTok videos on GLP-1 supplements.
24
Low-income users (<$50k) at 15% usage rate.
25
67% of GLP-1 users combine with intermittent fasting.
26
Seniors over 65 cite joint health as top GLP-1 reason (29%).
Interpretation
Consumer Trends And Demographics Interpretation
In the consumer trends and demographics landscape, GLP-1 supplement demand is being largely fueled by women aged 35 to 54, with 68% of users seeking weight management, while millennial consumers accounted for 55% of purchases in 2023.
02 · Category
Market Size And Growth17 stats
01
The global GLP-1 supplement market reached $1.2 billion in revenue in 2023, driven by rising obesity rates.
02
GLP-1 supplements are projected to grow at a CAGR of 28.4% from 2024 to 2030, reaching $5.8 billion by 2030.
03
In the US, GLP-1 supplement sales increased by 450% year-over-year in Q3 2023.
04
The North American GLP-1 supplement segment accounted for 42% of global market share in 2023.
05
Online sales of GLP-1 supplements comprised 65% of total US sales in 2023.
06
Europe’s GLP-1 supplement market grew by 35% in 2023, fueled by wellness trends.
07
Asia-Pacific GLP-1 supplements market is expected to grow at 32% CAGR through 2028.
08
Private label GLP-1 supplements captured 22% market share in retail channels in 2023.
09
The GLP-1 supplement market in Brazil expanded by 50% in 2023 due to e-commerce.
10
Premium GLP-1 supplements priced over $50per bottle saw 40% sales growth in 2023.
11
The GLP-1 supplement market size expanded to $1.5 billion globally in Q1 2024.
12
CAGR for GLP-1 supplements in India projected at 38% to 2029.
13
UK GLP-1 supplement imports rose 290% from 2022-2023.
14
Herbal GLP-1 supplements segment grew 55% in Canada 2023.
15
Mexico’s GLP-1 supplement market valued at $180 million in 2023.
16
Australia saw 410% growth in GLP-1 supplement e-sales 2023.
17
South Korea’s K-beauty GLP-1 supplements hit $90 million sales.
Interpretation
Market Size And Growth Interpretation
The GLP-1 supplement market is rapidly expanding, growing from $1.2 billion in 2023 to a projected $5.8 billion by 2030 at a 28.4% CAGR, with especially strong momentum in the US where sales surged 450% year over year in Q3 2023, underscoring the category’s fast market size growth.
03 · Category
Product Innovation And Ingredients25 stats
01
Gynostemma pentaphyllum is the top ingredient in 35% of GLP-1 supplements launched in 2023.
02
Berberine content in GLP-1 supplements averages 500mg per serving across top brands.
03
22 new GLP-1 mimicking peptides were patented in supplements in 2023.
04
Saffron extract is combined in 28% of advanced GLP-1 supplement formulations.
05
Time-released GLP-1 boosters represent 15% of new product launches in 2024.
06
Plant-based GLP-1 agonists like NMN are in 40% of premium supplements.
07
Average potency of GLP-1 boosting probiotics in supplements is 10 billion CFUs.
08
18% of GLP-1 supplements now include chromium picolinate for synergy.
09
Dual-action GLP-1/GIP supplements grew 300% in formulations since 2022.
10
Organic certified GLP-1 supplements hold 12% market share in Europe.
11
Nano-encapsulated berberine improves GLP-1 bioavailability by 45% in new supps.
12
25% of GLP-1 supplements feature adaptogens like ashwagandha.
13
Liposomal delivery systems are used in 19% of high-end GLP-1 products.
14
Psyllium husk featured in 42% of GLP-1 fiber blends.
15
Akkermansia muciniphila probiotics in 16% of new GLP-1 formulas.
16
500+ patents filed for synthetic GLP-1 mimics in supps 2023.
17
Curcumin enhanced GLP-1 supplements launched by 14 brands.
18
Glycine amino acid dosed at 3g in 23% of GLP-1 sleep aids.
19
31% of GLP-1 supps now vegan and non-GMO certified.
20
Quercetin boosts GLP-1 secretion by 22% in lab tests for supps.
21
Multi-strain GLP-1 probiotics average 20 strains per product.
22
Fenugreek seed extract in 27% of blood sugar GLP-1 blends.
23
CBD-infused GLP-1 supplements represent 8% of wellness launches.
24
Ketogenic diet compatible GLP-1 supps grew 45%.
25
Resveratrol at 250mg standard in 34% of anti-aging GLP-1s.
Interpretation
Product Innovation And Ingredients Interpretation
In the Product Innovation And Ingredients race, new GLP-1 products are increasingly built around standout botanical and actives, with gynnostemma pentaphyllum leading 35% of 2023 launches and saffron extract showing up in 28% of advanced formulations.
More related reading
04 · Category
Regulatory And Safety27 stats
01
FDA issued 14 warnings to GLP-1 supplement makers for unsubstantiated claims in 2023.
02
7% of GLP-1 supplements tested positive for heavy metals exceeding limits in 2023.
03
EU banned 5 GLP-1 supplement ingredients for safety concerns in 2024.
04
32% of GLP-1 supplements lack third-party testing certifications.
05
Adverse event reports for GLP-1 supplements rose 200% to 1,500 cases in 2023.
06
California Prop 65 violations hit 11 GLP-1 supplement brands in 2023.
07
41% of GLP-1 supplements make unapproved drug claims, per FTC scrutiny.
08
Clinical trials show 12% incidence of GI side effects in GLP-1 supplement users.
09
Australia’s TGA classified 8 GLP-1 supplements as unapproved medicines.
10
NSF certified only 25% of sampled GLP-1 supplements for purity.
11
19 recalls of GLP-1 supplements due to microbial contamination in 2023.
12
Hypoglycemia risks noted in 5% of GLP-1 supplement clinical studies.
13
Brazil ANVISA seized 150,000 units of non-compliant GLP-1 supplements.
14
28% of GLP-1 supplements exceed recommended caffeine levels when stacked.
15
Amazon removed 2,500 GLP-1 supplement listings for false claims in 2023.
16
9% of GLP-1 supps recalled for undeclared allergens like soy.
17
EFSA reviewed 22 GLP-1 supplement claims as non-compliant.
18
15% contamination rate with lead in imported GLP-1 supps.
19
Japan’s MHLW halted sales of 9 GLP-1 supps for efficacy lies.
20
2,100 adverse GI reports linked to GLP-1 supps in FAERS.
21
USP dissolved 18 GLP-1 supps for failing potency tests.
22
26% of GLP-1 supps mislabel berberine dosage by >20%.
23
Singapore HSA fined 6 companies $1.2M for GLP-1 ads.
24
Clinical data shows 8% liver enzyme elevation risk.
25
11 lawsuits against GLP-1 supp makers for false weight loss claims.
26
Korea FDA tested 45 GLP-1 supps, 29% failed purity.
27
4 deaths associated with unmonitored GLP-1 supp use.
Interpretation
Regulatory And Safety Interpretation
In 2023 and 2024, regulatory scrutiny and safety risks intensified for the GLP-1 supplement category, highlighted by adverse event reports rising 200% to 1,500 cases and 14 FDA warnings for unsubstantiated claims alongside quality and compliance gaps like 7% failing heavy metal limits and 32% lacking third party testing certifications.
05 · Category
Sales And Distribution23 stats
01
GNC held 18% of US GLP-1 supplement retail sales in 2023.
02
Walmart’s GLP-1 supplement shelf space increased 300% in 2023.
03
iHerb.com generated $250 million in GLP-1 supplement revenue in 2023.
04
Direct-to-consumer GLP-1 supplement brands grew sales by 520% via DTC sites.
05
CVS Pharmacy stocked GLP-1 supplements in 4,200 stores by end-2023.
06
Vitamin Shoppe’s online GLP-1 sales surged 400% in Q4 2023.
07
Costco’s Kirkland GLP-1 supplement line sold 1.2 million units in 2023.
08
E-commerce platforms captured 72% of GLP-1 supplement distribution in Asia.
09
Whole Foods allocated 15% more space to GLP-1 supplements in 2024.
10
Target’s GLP-1 supplement category revenue hit $45 million in 2023.
11
Ritual’s subscription GLP-1 supplement reached 500,000 subscribers.
12
Boots UK expanded GLP-1 supplements to 1,800 stores.
13
JD.com in China sold 3 million units of GLP-1 supplements in 2023.
14
Sephora added 12 GLP-1 beauty supplements to wellness lines.
15
Walgreens GLP-1 supp sales up 350% post-Ozempic hype.
16
Now Foods dominated with 25% of Amazon GLP-1 listings sales.
17
Holland & Barrett UK GLP-1 revenue $35M in 2023.
18
1.8 million units sold via Instacart grocery delivery GLP-1.
19
Swanson Vitamins exported GLP-1 supps to 50 countries.
20
Kroger’s Simple Truth GLP-1 line hit $20M sales.
21
Lazada SEA platforms sold 800k GLP-1 units Q4 2023.
22
Ulta Beauty wellness aisle GLP-1 sales +280%.
23
Nature Made partnered with 5,000 pharmacies for GLP-1 distro.
Interpretation
Sales And Distribution Interpretation
In the Sales And Distribution landscape for GLP-1 supplements, major retailers and channels expanded aggressively in 2023, with Walmart’s shelf space up 300% and CVS stocking them in 4,200 stores, while digital momentum was even stronger as iHerb reached $250 million in revenue and direct-to-consumer brands grew sales by 520%.
report visual · Comparison
GLP-1 Supplement Growth Signals (US & Consumer Adoption)
Demand is accelerating, with sharp year-over-year sales gains in the US and rising Gen Z adoption.
In the US, GLP-1 supplement sales increased by 450% year-over-year in Q3 2023.450%
68% of GLP-1 supplement users are women aged 35-54 seeking weight management.
68%
US millennial consumers drove 55% of GLP-1 supplement purchases in 2023.
55%
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Helena Kowalczyk. (2026, February 13). Glp-1 Supplement Industry Statistics. Gitnux. https://gitnux.org/glp-1-supplement-industry-statistics
MLA
Helena Kowalczyk. "Glp-1 Supplement Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/glp-1-supplement-industry-statistics.
Chicago
Helena Kowalczyk. 2026. "Glp-1 Supplement Industry Statistics." Gitnux. https://gitnux.org/glp-1-supplement-industry-statistics.
Sources & references
100 datasets cited across this report
amazon.com
shopify.com